MPEP § 2419.01 — Patent Grants and Patent Application Publications Containing a Non-Lengthy “Sequence Listing XML” (Annotated Rules)
§2419.01 Patent Grants and Patent Application Publications Containing a Non-Lengthy “Sequence Listing XML”
This page consolidates and annotates all enforceable requirements under MPEP § 2419.01, including statutory authority, regulatory rules, examiner guidance, and practice notes. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.
Patent Grants and Patent Application Publications Containing a Non-Lengthy “Sequence Listing XML”
This section addresses Patent Grants and Patent Application Publications Containing a Non-Lengthy “Sequence Listing XML”.
Key Rules
Sequence Listing Content
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
Citations
| Primary topic | Citation |
|---|---|
| Sequence Listing Content | 37 CFR § 1.831(b) |
Source Text from USPTO’s MPEP
This is an exact copy of the MPEP from the USPTO. It is here for your reference to see the section in context.
Official MPEP § 2419.01 — Patent Grants and Patent Application Publications Containing a Non-Lengthy “Sequence Listing XML”
Source: USPTO2419.01 Patent Grants and Patent Application Publications Containing a Non-Lengthy “Sequence Listing XML” [R-01.2024]
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
Upon transformation of the .xml file using the style sheet to an ASCII text file, any ASCII text file produced by the USPTO that is under 600KB will be published as part of the specification.